Neurology

Results from a new study show that older adults with untreated hypertension had a 42% increased risk of dementia vs healthy controls.

Your daily dose of the clinical news you may have missed.

A recent study of patients with chronic low back pain sheds light on the association between sleep and opioid use on pain severity and interference.

Women with an evening vs morning chronotype were 54% more likely to have unhealthy lifestyles that in turn accounted for a significant increased risk for diabetes.

Your daily dose of clinical news you may have missed.

Elevated inflammation, rather than depression, may drive poor weight loss outcomes in patients with obesity following bariatric surgery, suggest authors of new study.

Get a quick look at the US worst states for health care ranked using a composite score that included measures of cost, access, and outcomes.

Results from a new study suggest that postnatal SSRI treatment may be beneficial in the long term for both women with postpartum depression and their children.

Atrial fibrillation prevalence is rising across socioeconomic strata globally, the new analysis finds, with effects of BMI, ETOH, and sedentary behavior shifting as key drivers.

Your daily dose of clinical news you may have missed.

Oldest and most frail elderly were at more than 60% greater risk of bleeding when switched from a VKA than those who remained on the traditional agent.

The first biosimilar to the approved formulation of natalizumab is indicated for relapsing forms of MS and for induction/maintenance of remission in adults with Crohn disease.

The device from Nexalin Technology outperformed placebo on key measures of pain relief, sleep quality, anxiety, and quality of life.

An overview of oral preventive medication options for migraine for primary care clinicians, here.

A daily dose of clinical news on Patient Care you may have missed.

The reduction in risk of CV events, the first to be shown by an antiobesity drug, was higher than expected and could help alter perceptions of the agents as "lifestyle drugs."

The oral gepant reduced monthly migraine days as well as mean monthly use of migraine rescue medication.

The end of another quarter means a new list of FDA-approved drugs for primary care. Which ones should you know about?

The Alzheimer's Association chief science officer discusses release of updated diagnostic guidelines for AD, which incorporate use of plasma-based biomarkers.

A daily dose of clinical news on Patient Care you may have missed.

A new analysis of the ASPREE trial of aspirin for primary prevention in older adults finds a poor risk-benefit ratio for prevention of stroke.

A majority of older adults agree that all aged ≥65 years should be screened annually for dementia; more than half significantly fear a positive result, the National Poll on Healthy Aging reports.

When is a primary care patient with back pain ready for referral to PM&R? No formulas available but basic principles hold true and earlier is always better.

A daily dose of clinical news you may have missed.

The highest risk of mortality among a Danish population with dementia occurred within 2 weeks of an opioid prescription but remained significant at 180 days.